SK285865B6 - Farmaceutický prostriedok s maskovanou chuťou a spôsob jeho prípravy - Google Patents

Farmaceutický prostriedok s maskovanou chuťou a spôsob jeho prípravy Download PDF

Info

Publication number
SK285865B6
SK285865B6 SK1592-2003A SK15922003A SK285865B6 SK 285865 B6 SK285865 B6 SK 285865B6 SK 15922003 A SK15922003 A SK 15922003A SK 285865 B6 SK285865 B6 SK 285865B6
Authority
SK
Slovakia
Prior art keywords
matrix
polymer
composition according
composition
alkaline
Prior art date
Application number
SK1592-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK15922003A3 (sk
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schwabe
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of SK15922003A3 publication Critical patent/SK15922003A3/sk
Publication of SK285865B6 publication Critical patent/SK285865B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1592-2003A 2001-06-21 2002-06-21 Farmaceutický prostriedok s maskovanou chuťou a spôsob jeho prípravy SK285865B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
SK15922003A3 SK15922003A3 (sk) 2004-05-04
SK285865B6 true SK285865B6 (sk) 2007-10-04

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1592-2003A SK285865B6 (sk) 2001-06-21 2002-06-21 Farmaceutický prostriedok s maskovanou chuťou a spôsob jeho prípravy

Country Status (42)

Country Link
US (2) US7138138B2 (es)
EP (1) EP1401397B1 (es)
JP (1) JP4880871B2 (es)
CN (1) CN1239149C (es)
AP (1) AP1595A (es)
AR (1) AR036096A1 (es)
AT (1) ATE290366T1 (es)
AU (1) AU2002329311B2 (es)
BG (1) BG66314B1 (es)
BR (1) BRPI0208998A2 (es)
CA (1) CA2452239C (es)
CO (1) CO5540278A2 (es)
CZ (1) CZ299947B6 (es)
DE (1) DE60203178T2 (es)
EA (1) EA006016B1 (es)
EC (1) ECSP034915A (es)
ES (1) ES2236574T3 (es)
FR (1) FR2826274B1 (es)
GT (2) GT200200115A (es)
HK (1) HK1067558A1 (es)
HR (1) HRP20031067B1 (es)
HU (1) HUP0400799A3 (es)
IL (2) IL159404A0 (es)
JO (1) JO2325B1 (es)
MA (1) MA27042A1 (es)
MX (1) MXPA03011756A (es)
MY (1) MY134340A (es)
NO (1) NO332258B1 (es)
NZ (1) NZ530042A (es)
OA (1) OA12635A (es)
PA (1) PA8548301A1 (es)
PE (1) PE20030201A1 (es)
PL (1) PL202090B1 (es)
PT (1) PT1401397E (es)
SK (1) SK285865B6 (es)
SV (1) SV2003001098A (es)
TN (1) TNSN03141A1 (es)
TW (1) TWI228049B (es)
UA (1) UA77960C2 (es)
UY (1) UY27341A1 (es)
WO (1) WO2003000225A2 (es)
ZA (1) ZA200309479B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
WO2007090721A1 (de) * 2006-02-03 2007-08-16 Evonik Röhm Gmbh Pharmazeutische zusammensetzungen, enthaltend mischungen aus polymeren und in wasser schlecht löslichen wirkstoffen
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JP5597204B2 (ja) 2008-12-16 2014-10-01 カールスベア アー／エス 気相グラフティングによってヒドロキシル化された表面のコーティング
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
JP2017523975A (ja) * 2014-08-05 2017-08-24 センプラ ファーマシューティカルズ，インコーポレイテッド 経口抗菌薬粉末懸濁製剤
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
WO1999017742A2 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations
IN191239B (es) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
EP1313751B1 (en) * 2000-08-22 2008-09-17 Basilea Pharmaceutica AG New macrolides with antibacterial activity

Also Published As

Publication number Publication date
MXPA03011756A (es) 2004-07-01
CO5540278A2 (es) 2005-07-29
DE60203178T2 (de) 2006-01-26
UY27341A1 (es) 2003-01-31
ATE290366T1 (de) 2005-03-15
PL366803A1 (en) 2005-02-07
CN1529585A (zh) 2004-09-15
NZ530042A (en) 2005-09-30
AP2003002927A0 (en) 2003-12-31
PL202090B1 (pl) 2009-06-30
JP2004534810A (ja) 2004-11-18
CZ299947B6 (cs) 2009-01-07
HRP20031067B1 (en) 2011-10-31
IL159404A0 (en) 2004-06-01
SK15922003A3 (sk) 2004-05-04
FR2826274B1 (fr) 2003-09-26
JO2325B1 (en) 2006-06-28
ECSP034915A (es) 2004-02-26
US7138138B2 (en) 2006-11-21
UA77960C2 (en) 2007-02-15
FR2826274A1 (fr) 2002-12-27
SV2003001098A (es) 2003-03-18
CA2452239A1 (fr) 2003-01-03
HK1067558A1 (en) 2005-04-15
BG66314B1 (bg) 2013-04-30
AR036096A1 (es) 2004-08-11
ZA200309479B (en) 2005-04-26
DE60203178D1 (de) 2005-04-14
IL159404A (en) 2007-08-19
AU2002329311B2 (en) 2007-02-01
GT200200115AA (es) 2005-01-12
BG108458A (bg) 2005-02-28
MY134340A (en) 2007-12-31
AP1595A (en) 2006-04-12
HUP0400799A3 (en) 2012-08-28
EA006016B1 (ru) 2005-08-25
EP1401397B1 (fr) 2005-03-09
US20070014857A1 (en) 2007-01-18
PE20030201A1 (es) 2003-03-12
JP4880871B2 (ja) 2012-02-22
GT200200115A (es) 2003-02-27
PA8548301A1 (es) 2003-09-05
PT1401397E (pt) 2005-05-31
CZ20033441A3 (en) 2004-03-17
TWI228049B (en) 2005-02-21
CN1239149C (zh) 2006-02-01
HUP0400799A2 (hu) 2004-08-30
ES2236574T3 (es) 2005-07-16
MA27042A1 (fr) 2004-12-20
OA12635A (fr) 2006-06-15
CA2452239C (fr) 2011-07-19
HRP20031067A2 (en) 2004-04-30
BRPI0208998A2 (pt) 2017-06-06
WO2003000225A2 (fr) 2003-01-03
NO332258B1 (no) 2012-08-13
TNSN03141A1 (fr) 2005-12-23
WO2003000225A3 (fr) 2003-03-13
EA200400061A1 (ru) 2004-06-24
EP1401397A2 (fr) 2004-03-31
NO20035581D0 (no) 2003-12-15
US20040142029A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
US20070014857A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
EP1248616B1 (en) Functional coating of linezolid microcapsules for oral administration
EP1194153B1 (en) Taste masked pharmaceutical liquid formulations
US20030083354A1 (en) Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
WO1997002020A1 (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
BG104634A (bg) Микрогранули от омепразол със стомашно защитно действие, метод за тяхното получаване и фармацевтични препарати
WO2004087096A1 (en) Pharmaceutical compositions having reduced bitter taste
US20040241235A1 (en) Granules and granules coated with a masked taste
US20080125453A1 (en) Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
ZA200207737B (en) Granulated particles with masked taste.
SK134896A3 (en) Coated ranitidine tablet and method for producing said coating
HU214825B (hu) Eljárás spiramicint tartalmazó gyógyszerkészítmények előállítására
WO2001085134A1 (en) Pharmaceutical solid compositions and process for the production of mouth dissolving tablets
KR20040040959A (ko) 쓴맛이 은폐된 세파계 항생제의 조성물 및 그의 제조방법

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150621